Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
SHC · Nasdaq · United States · Services-Misc Health & Allied Services, Nec
In shortSotera Health Co is profitable, generates cash and carries heavy debt, with revenue growing (+5.7% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | – | n/a |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 6.7% | 47/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 15.4% | 77/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.46× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 3.53× | 0/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 12.8% | 71/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.91× | 100/100 |
| Years with positive free cash flow (last 5) | 4 of 5 | 75/100 |
Weight in the score: 20%
| Profitable years (last 5) | 4 of 5 | 80/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 3.8% | 97/100 |
| Operating margin volatility | 1.2% | 98/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 5.1% | 45/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 931 | 1,004 | 1,049 | 1,100 | 1,164 |
| Cost of revenue | 413 | 447 | 472 | 498 | 518 |
| Gross profit | 519 | 557 | 577 | 602 | 646 |
| Selling, general & admin | 198 | 246 | 237 | 243 | 253 |
| Operating income | 257 | 248 | 277 | 298 | – |
| Pre-tax income | 176 | (243) | 106 | 114 | 148 |
| Income tax | 59 | (9.5) | 55 | 69 | 70 |
| Net income | 117 | (234) | 51 | 44 | 78 |
| Diluted EPS | $0.41 | −$0.83 | $0.18 | $0.16 | $0.27 |
| Diluted shares (millions) | 279 | 280 | 283 | 285 | 286 |
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of Sotera Health Co are included in the Investor plan. Try free for 7 days →
Not computed: a required balance-sheet item is missing.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026